422
Gynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered.
 two epileptic patients: Subject; two: Subject.Population; Gynecomastia: Effect; some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered: Treatment; oral: Treatment.Route; fluoresone: Treatment.Drug; phenobarbital: Treatment.Drug; phenytoin: Treatment.Drug; 750 mg: Treatment.Dosage; daily: Treatment.Freq; epileptic: Treatment.Disorder; some months after: Treatment.Time_elapsed; fluoresone: Combination.Drug; phenobarbital: Combination.Drug; phenytoin: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 two epileptic patients: Subject; two: Subject.Population; Gynecomastia: Effect; some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered: Treatment; oral: Treatment.Route; fluoresone: Treatment.Drug; phenobarbital: Treatment.Drug; phenytoin: Treatment.Drug; 750 mg: Treatment.Dosage; daily: Treatment.Freq; epileptic: Treatment.Disorder; some months after: Treatment.Time_elapsed; fluoresone: Combination.Drug; phenobarbital: Combination.Drug; phenytoin: Combination.Drug